 |
|
 |
Tele |
|
0086-10-82600828 |
|
0086-10-82600893 |
|
Fax |
|
|
|
|
 |
Beneficial Name:Beijing Waterwood Technologies CO.,LTD |
|
|
Bank Name: Bank of Communications, Beijing Branch |
|
Bank Address: NO.1 jinxiyuan shijicheng,Landianchang,Haidian District,Beijing |
|
Bank Account No #: 110060668012015061217 |
|
Routing No # : 332906 |
|
Bank SWIFT Code ：COMMCNSHBJG |
|
|
|
|
 |
|
 |
| [组图]Company Study of Guangxi Wuzhou Zhongheng Group Co., Ltd., 2007 |
|
|
|
 |
|
| Company Study of Guangxi Wuzhou Zhongheng Group Co., Ltd., 2007 |
| 作者：佚名 Roport来源：本站原创 点击数： 更新时间：2007-8-29 |
| 【发表评论】【加入收藏】【告诉好友】【打印此文】【关闭窗口】【Text：Little louge】 |
|
Abstract
In 2006, the company received the main business revenue of RMB 321.1685 million, of which the pharmaceutical industry accounted for 62.83%; the profit of main business reached RMB 154.1201 million and, the net profit amounted to RMB 19.6635 million.
Xueshuantong Freeze-Dry Powder for Injection, the company's core pharmaceutical product, is an important variety in cardiovascular and cerebrovascular fields. At present, the company's full-loaded monthly production capacity can not meet the increased market demand, so some products are contracted to Chongqing Yaoyou Pharmaceutical temporarily. It is estimated that the sales volume of Xueshuantong Freeze-Dry Powder for Injection will be 25 million doses in 2007, and 40 million in 2008, 50 million in 2009.
Main Business Structure of Zhongheng Group, 2006
Source: ResearchInChina
Market Pattern of Drugs Used in Hospitals, 2006
Source: ResearchInChina
Table of Contents
1 Company profile
1.1 Equity rights transferred by SASAC
1.2 Strategies of the company
1.3 Management and marketing of the company
2. Analysis on cardiovascular drugs
2.1 Analysis on the market
2.2 Traditional Chinese medicine in cardiovascular field
2.3 Market status of the company's Xueshuantong (Freeze-Dry) Powder for Injection
3. Development of the company
3.1 Patent
3.2 Development of the company's pharmaceutical business in 2007
3.3 Status quo of the company's new base
Selected Charts
Equity structure of the company
Main business structure of Zhongheng Group, 2006
Market pattern of drugs used in hospitals, 2006
Variation in medicine sales income of Zhongheng Group
Parts of financial indicators of Zhongheng Group
Share and growth rate of sub-classified cardiovascular drugs, 2006
Classification of cardiovascular drugs and main varieties
Comparison of main traditional Chinese injection varieties
Patent application for main inventions of Guangxi Wuzhou Pharmaceuticals (Group) Co., Ltd
|
Published Date |
Number of Pages |
Publisher |
Price |
|
Aug/2007 |
23 |
ResearchInChina |
$349(PDF) |
|
$349(Hard Copy) | |
|
| Roport录入：wangyunling 责任编辑：wangyunling |
|
|
|
 |
|
您现在的位置： 
